Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 5Terminated 2Active not recruiting 1

Sponsor Class

OTHER 13NIH 5INDUSTRY 3

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Head & Neck 5Other neoplasm 1

Conditions

Breast Neoplasms 309Neoplasms 269Prostatic Neoplasms 189Precursor Cell Lymphoblastic Leukemia-Lymphoma 186Lymphoma 184Leukemia, Lymphocytic, Chronic, B-Cell 161Melanoma 158Leukemia 154Lymphoma, Non-Hodgkin 149Leukemia, Myeloid, Acute 149Brain Neoplasms 143Carcinoma, Non-Small-Cell Lung 141Lymphoma, Large B-Cell, Diffuse 128Colonic Neoplasms 128Lymphoma, Follicular 123Burkitt Lymphoma 119Ovarian Neoplasms 117Lung Neoplasms 116Glioblastoma 116Lymphoma, Mantle-Cell 114Unspecified Adult Solid Tumor, Protocol Specific 107Rectal Neoplasms 103Sarcoma 102Multiple Myeloma 102Gliosarcoma 102Hodgkin Disease 97Carcinoma, Renal Cell 97Lymphoma, B-Cell, Marginal Zone 96Astrocytoma 95Carcinoma, Ovarian Epithelial 93

Interventions

Rosiglitazone 1Pioglitazone 1Gene Expression Profiling 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × NIH × Leukoplakia, Oral × Clear all
NCT00341497 2025-07-31

Biomarkers for Oral Cancer

National Institutes of Health Clinical Center (CC)

Completed
80 enrolled
Head & Neck

Leukoplakia, Leukoplakia, Oral, Lichen Planus, Mouth Neoplasms

NCT00099021 2022-02-11

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 2 Completed
21 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Leukoplakia, Oral

NCT00330382 2014-12-19

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 2 Completed
325 enrolled 15 charts
Head & Neck

Leukoplakia, Oral, Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

NCT01238185 2013-08-12

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Head & NeckOther neoplasm

Leukoplakia, Oral, Precancerous Conditions

NCT00369174 2013-02-13

Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 2 Completed
25 enrolled
Head & Neck

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡